Possible Link Between Elmiron and Vision Loss
Elmiron, the brand name for pentosan polysulfate sodium (PPS), is a common prescription medication used to treat interstitial cystitis (IC) also known as painfu...
Risk of Type 2 Diabetes Associated with Adolescent SSRI Use
A recent study published by JAMA Psychiatry found a small increased risk for adolescents to develop type 2 diabetes as a result of using selective serotonin reu...
Elmiron Treatment and Vision Loss
A recent study out of the Emory School of Medicine suggests that the widely used bladder drug, Elmiron, may lead to irreversible vision loss in patients. Elmi...
Study Finds Increased Risk Between PPI Drugs and COVID-19 Infection
A study in The American Journal of Gastroenterology finds that people who take proton pump inhibitor (PPI) medication once or twice daily may be at a higher ris...
Common Type 2 Diabetes Medication may Contain Unsafe NDMA Levels
On May 28, 2020, the United States Food and Drug Administration (FDA) issued an alert to patients and healthcare providers that unsafe levels of N-Nitrosodimeth...
Prolonged Use of Elmiron may Cause Vision Problems
New findings suggest that Elmiron, also referred to as pentosan polysulfate sodium (PPS), can negatively affect an individual’s vision. This may occur when El...
The Dangers of Ranitidine and NDMA
Since the end of 2019, Ranitidine, commonly marketed as Zantac, has been subject to recall. It was revealed that Ranitidine contains trace amounts of NDMA, a po...
Drug Manufacturers Fail to Understand the Dangerousness of Zantac
At the end of last year the popular heartburn medication Zantac, or ranitidine, was recalled due to unsafe levels of N-nitrosodimethylamine (NDMA) found in it. ...
FDA Recalls Zantac Tablets Over Probable Carcinogen Found in Drug
Earlier this month the United States Food and Drug Administration (FDA) issued a recall statement on Ranitidine tablets after unacceptable levels of N-Nitrosodi...
Weight Loss Drug Pulled From Market After Being Linked to Cancer
The FDA recently issued a request for the manufacturer of the weight loss drug Belviq and Belviq XR (Lorcaserin) to be voluntarily pulled from the market after ...
